Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO, re-validated 148, is a catch all for the other 6 MMP patents and the 7 new

"but if we ever want to be taken seriously and get off the BB with a good following of anxious wannabe investors it wont be the MMP licensing that does that, and RG realizes that IMO."

Emtnester what if newer MMP license payments are recurring royalty payments over time? Wouldn't this new investors attitude towards the MMP.

All the best,

Steve

Share
New Message
Please login to post a reply